Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial

• Status: Completed
• Trial end date: 2017-01-17
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study was to investigate the effects of duloxetine on improvement of brain cortical activity in patients suffering from major depressive disorder using near infrared spectroscopy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Taichung Veterans General Hospital
• Treatments: Duloxetine Hydrochloride

Criteria

Inclusion Criteria:

• HAMD-17 more than 12 points

• Participants could understand this study and sign permit

• Participants could receive NIRS measurements

• Participants could comply with the protocol of the study

Exclusion Criteria:

• alcohol or substance abuse within 3 months of the study

• ever participate other clinical study related to duloxetine

• previous poor treatment effects of duloxetine

• concomitant use of MAOi within 14 days

• concomitant use of Linezolid

• with uncontrolled glaucoma